Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl

Alpha Cognition has started enrolling patients in its RESOLVE Phase IV study, which is evaluating Zunveyl as a treatment for mild-to-moderate Alzheimer’s. The post Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl appeared first on Clinical Trials Arena .